Oil prices edge lower as China’s GDP growth slows
Oil prices slipped on Monday after China posted its slowest quarterly economic growth in at least 27 years, reinforcing concerns about demand in the world’s largest crude oil importer.
Exclusive: U.S. firms may get nod to restart Huawei sales in two-four weeks – official
The U.S. may approve licenses for companies to re-start new sales to Huawei in as little as two weeks, according to a senior U.S. official, in a sign President Donald Trump’s recent effort to ease restrictions on the Chinese company could move forward …
Asian shares, dollar brace for China GDP
Asian shares started the week on a softer note on Monday after posting their first weekly decline since early June, while the dollar was on the defensive ahead of key economic data from China.
Exclusive: U.S. firms may get nod to restart Huawei sales in 2-4 weeks – official
The U.S. may approve licenses for companies to re-start new sales to Huawei in as little as two weeks, according to a senior U.S. official, in a sign President Donald Trump’s recent effort to ease restrictions on the Chinese company could move forward …
Amazon workers in Germany to strike over pay, Verdi union says
Workers at seven Amazon sites across Germany will go on strike over pay for at least two days this week starting on Sunday night going into Monday, labor union Verdi said.
U.S. proposes barring big tech companies from offering financial services, digital currencies
A proposal to prevent big technology companies from functioning as financial institutions or issuing digital currencies has been circulated for discussion by the Democratic majority that leads the House Financial Services Committee, according to a copy…
Gilead deepens Galapagos ties with $5.1 billion deal
Gilead Sciences Inc will invest $5.1 billion to raise its stake in Galapagos NV and partner with the Belgian-Dutch biotech firm to develop and commercialize its treatments for a ten-year period, the companies said on Sunday.
Pharma firm Gilead to raise Galapagos stake in $5.1 billion deal
Gilead Sciences Inc will invest $5.1 billion to increase its stake in Galapagos NV and partner with the Belgian-Dutch biotech firm to develop and commercialize its treatments for a ten-year period, the companies said on Sunday.
U.S. Fed seen launching repo facility in early 2020: Deutsche Bank
The Federal Reserve may launch a policy tool to lend to banks using Treasuries and other securities as collateral in early 2020, with possible testing to begin later this year, a Deutsche Bank strategist said.
GSK in talks to name HSBC’s Symonds as its next chairman: Bloomberg
GlaxoSmithKline Plc is in talks to name HSBC’s deputy chairman Jonathan Symonds as the next chairman of the British drugmaker, Bloomberg reported on Sunday, citing a person familiar with the matter.
